Cargando…
hMSCs suppress neutrophil-dominant airway inflammation in a murine model of asthma
Although chronic eosinophilic inflammation is a common feature in patients with asthma, some patients have neutrophil-dominant inflammation, which is known to be associated with severe asthma.Human mesenchymal stem cells (hMSCs) have shown promise in treating various refractory immunological disease...
Autores principales: | Hong, Gyong Hwa, Kwon, Hyouk-Soo, Lee, Kyoung Young, Ha, Eun Hee, Moon, Keun-Ai, Kim, Seong Who, Oh, Wonil, Kim, Tae-Bum, Moon, Hee-Bom, Cho, You Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291839/ https://www.ncbi.nlm.nih.gov/pubmed/28127050 http://dx.doi.org/10.1038/emm.2016.135 |
Ejemplares similares
-
S-adenosylmethionine reduces airway inflammation and fibrosis in a murine model of chronic severe asthma via suppression of oxidative stress
por: Yoon, Sun-Young, et al.
Publicado: (2016) -
hMSCs as an alternative therapeutic option for asthma with neutrophil mediated inflammation
por: Cruz, Fernanda F., et al.
Publicado: (2018) -
IL-32γ attenuates airway fibrosis by modulating the integrin-FAK signaling pathway in fibroblasts
por: Hong, Gyong Hwa, et al.
Publicado: (2018) -
Proliferation and Osteogenic Differentiation of hMSCs on Biomineralized Collagen
por: de Melo Pereira, Daniel, et al.
Publicado: (2020) -
(18)F- based Quantification of the Osteogenic Potential of hMSCs
por: Grossner, Tobias, et al.
Publicado: (2020)